Ignite Creation Date:
2024-05-06 @ 1:09 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01745120
Status:
COMPLETED
Last Update Posted:
2019-05-08
First Post:
2012-12-06
Brief Title:
A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants
Sponsor:
bluebird bio
Organization:
bluebird bio
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2018-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-06
First Submit QC Date:
December 6 2012
Study First Post Date:
2012-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-16
Last Update Post Date:
2019-05-08
Last Update Post Date Type:
ACTUAL